Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.16 USD | +0.64% | -10.73% | +90.36% |
05-30 | Cantor Fitzgerald Initiates ADC Therapeutics at Overweight Rating | MT |
05-07 | HC Wainwright Adjusts Price Target on ADC Therapeutics to $8 From $9, Maintains Buy Rating | MT |
Sales 2024 * | 77.83M 107M | Sales 2025 * | 90.51M 124M | Capitalization | 304M 418M |
---|---|---|---|---|---|
Net income 2024 * | -179M -246M | Net income 2025 * | -172M -236M | EV / Sales 2024 * | 2.23 x |
Net cash position 2024 * | 130M 179M | Net cash position 2025 * | 88.83M 122M | EV / Sales 2025 * | 2.38 x |
P/E ratio 2024 * |
-1.67
x | P/E ratio 2025 * |
-2
x | Employees | 274 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 74.36% |
Latest transcript on ADC Therapeutics SA
1 day | +0.64% | ||
1 week | -10.73% | ||
Current month | -7.87% | ||
1 month | -26.51% | ||
3 months | -28.99% | ||
6 months | +206.80% | ||
Current year | +90.36% |
Managers | Title | Age | Since |
---|---|---|---|
Ameet Mallik
CEO | Chief Executive Officer | 51 | 22-05-08 |
Jose Carmona
DFI | Director of Finance/CFO | 51 | 22-12-18 |
Mohamed Zaki
CTO | Chief Tech/Sci/R&D Officer | 59 | 23-01-02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Peter Hug
BRD | Director/Board Member | 65 | 19-05-31 |
Ron Squarer
CHM | Chairman | 57 | 20-03-31 |
Jean Bizzari
BRD | Director/Board Member | 69 | 22-06-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 0 M€ | 0.00% | - | |
0.02% | 0 M€ | 0.00% | - | |
0.01% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-06-12 | 3.16 | +0.64% | 2,058,218 |
24-06-11 | 3.14 | -13.74% | 801,051 |
24-06-10 | 3.64 | +6.43% | 395,515 |
24-06-07 | 3.42 | -1.72% | 927,871 |
24-06-06 | 3.48 | -1.69% | 235,103 |
Delayed Quote Nyse, June 12, 2024 at 04:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+90.36% | 304M | |
+16.93% | 123B | |
+17.01% | 111B | |
-7.23% | 23.63B | |
+3.09% | 22.58B | |
-14.20% | 17.26B | |
-6.79% | 17.6B | |
-37.63% | 17.61B | |
+2.17% | 13.55B | |
+24.42% | 11.34B |
- Stock Market
- Equities
- ADCT Stock